ABBV

Abbvie Inc.

A global biopharmaceutical company, AbbVie develops and sells medicines for immune, nerve, and cancer conditions — brands include Skyrizi, Rinvoq, Humira, Botox, and Imbruvica — as well as cosmetic treatments like Botox Cosmetic and the Juvederm line. It was born in 2013 when Abbott Laboratories split, spinning off its drug business into a fresh company. Fun fact: the name blends "Abb" (from Abbott) with "Vie," echoing the Latin word for "life," and insiders noted it conveniently rhymes with "R&D."

Recent Activity

Show $

2026Q2

1 buy6 sells

Bridgewater Associates LPTRIM

-18.6K shares(-61.2%)

Bridgewater Associates LPTRIM

-18.6K shares(-61.2%)

Harris AssociatesTRIM

-262 shares(-9.8%)

Harris AssociatesTRIM

-262 shares(-9.8%)

Jensen Investment ManagementTRIM

-80 shares(-0.7%)

Jensen Investment ManagementTRIM

-80 shares(-0.7%)

Mairs & PowerTRIM

-615 shares(-1.4%)

Mairs & PowerTRIM

-615 shares(-1.4%)

Matrix Asset AdvisorsTRIM

-105 shares(-0.3%)

Matrix Asset AdvisorsTRIM

-105 shares(-0.3%)

Torray Equity Income FundADD

+5.4K shares(+7.7%)

Torray Equity Income FundADD

+5.4K shares(+7.7%)

Torray Investment PartnersTRIM

-11.0K shares(-11.7%)

Torray Investment PartnersTRIM

-11.0K shares(-11.7%)

2026Q1

3 buys1 sell

Bridgewater Associates LPADD

+16.2K shares(+113.7%)

Bridgewater Associates LPADD

+16.2K shares(+113.7%)

Mairs & PowerTRIM

-1.1K shares(-2.5%)

Mairs & PowerTRIM

-1.1K shares(-2.5%)

Matrix Asset AdvisorsADD

+890 shares(+2.3%)

Matrix Asset AdvisorsADD

+890 shares(+2.3%)

Torray Investment PartnersADD

+901 shares(+1.0%)

Torray Investment PartnersADD

+901 shares(+1.0%)

Loading more activity...